Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Time to first rescue antiemetic after two dual-drug regimens for PONV in gallbladder surgery

Official title: Time-to-first-rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy: a Randomized, Triple-Blind, Superiority Trial

Run by Faisalabad Medical University · NCT07638527 · Data updated 2026-11-12

This trial tests whether ondansetron plus metoclopramide delays the need for rescue antiemetic more than dexamethasone plus metoclopramide in adults at moderate-to-high risk undergoing laparoscopic cholecystectomy.

More Postoperative Nausea and Vomiting trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment264 (estimated)
SponsorFaisalabad Medical University
Academic / other
Locations1 site (Faisalābad, Punjab Province)
StatusRecruiting
StartedSeptember 2026
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT07638527 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with ASA I–II, scheduled for elective laparoscopic cholecystectomy, and Apfel score 2–4.

Probably not a fit

Patients with low PONV risk (Apfel 0–1), contraindications to study drugs, or those who do not respond to rescue antiemetic.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a phase 4, randomized, superiority trial comparing two combination antiemetic strategies given before anesthesia in adults with moderate-to-high risk of PONV undergoing elective laparoscopic cholecystectomy. Participants are assigned to either ondansetron 4 mg plus metoclopramide 10 mg IV or dexamethasone 8 mg IV plus metoclopramide 10 mg IV, with the primary outcome being time to first rescue antiemetic within 24 hours post-surgery. The study administers blinded treatment shortly before anesthesia and provides rescue metoclopramide for vomiting or severe nausea, with in-hospital monitoring for 24 hours. The trial aims to determine whether the ondansetron combination provides better PONV control than the dexamethasone combination.

Why it matters

Potential benefit: If successful, the ondansetron combination could extend time to rescue antiemetic and improve comfort for patients after gallbladder surgery.

How similar studies have gone: Previous studies with dual-drug antiemetic strategies have shown beneficial effects in PONV prevention, supporting exploration of different drug combinations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* American Society of Anesthesiologists (ASA) physical status I or II
* Scheduled for elective laparoscopic cholecystectomy
* Apfel score 2-4 (moderate to high risk for PONV)
* Provides written informed consent prior to enrollment

Exclusion Criteria:

* Known allergy or hypersensitivity to ondansetron, dexamethasone, or metoclopramide
* Emergency surgery (e.g., acute cholecystitis, perforation, or gangrene)
* Pregnancy or breastfeeding
* ASA physical status III or IV
* Preexisting hepatic impairment
* Baseline corrected QT (QTc) interval \> 420 ms on pre-operative ECG
* History of dystonic reaction to metoclopramide or other dopamine antagonists
* Preexisting renal impairment (e.g., serum creatinine \> 1.5 mg/dL or on dialysis)
* Unable or unwilling to provide informed consent

Where it's running

  • Faisalabad Medical University
    Faisalābad, Punjab Province, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Asifa Saeed, MBBS; FCPS — Faisalabad Medical University
  • Study coordinator: Asifa Saeed, MBBS; FCPS
  • Email: drasifasaeed@gmail.com
  • Phone: +923006694460

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.